Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
Pediatric Terrorism and Disaster Preparedness

Public Health Emergency Preparedness

This resource was part of AHRQ's Public Health Emergency Preparedness program, which was discontinued on June 30, 2011, in a realignment of Federal efforts.

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Table 6.10. Radionuclide Specific Therapies

Radionuclide Therapy Mechanism of Action
Iodine KI Blocks thyroid deposition
Cesium/Rubidium/Thallium Prussian blue Blocks gastrointestinal (GI) absorption and prevents recycling
Plutonium and transuranics (Americium, Californium, Lanthanum, Curium) DTPA Acts as chelating agent
Uranium Bicarbonate Alkalinizes urine, decreases chances of acute tubular necrosis
Tritium Forced fluids, diuretics Dilutes isotope
Strontium Oral aluminum phosphate or barium sulfate Blocks GI absorption
Radium Magnesium sulfate lavage Prevents absorption
Phosphorus Stomach lavage, aluminum hydroxide, oral phosphates Prevents absorption, blocks cellular deposition
Cobalt Gastric lavage, purgatives; penicillamine if severe Prevents absorption, acts as chelating agent

Source: National Council on Radiation Protection and Measurements. Management of Persons Accidentally Contaminated with Radionuclides, Report Number 65, 1979. Bethesda, MD. Reprinted with permission.

Return to Document

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care